#personalized medicine — Saturday, August 29, 2026 (1 items)
| 0 | ℹ |
Distinct multi-omics signatures of clinical subgroups of type 2 diabetes define heterogeneous responses to an insulin sensitizer.
(nature.com)
|
Nature Communications 2026-08-29 | #diabetes #metabolomics #microrna #personalized medicine #drug response |